The Latest Breaking News from FDA

U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease

The blend of growth potential and stability in mid-cap pharma stocks is driven by rising demand for innovative therapies, strong economic conditions, and technological advancements that boost the sector's growth trajectory. Therefore, considering strong mid-cap stocks like Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and ACADIA Pharmaceuticals (ACAD), expected to soar…

The resilience and lower volatility of consumer staples stocks make them reliable choices for long-term, steady growth. Thus, it could be wise to invest in fundamentally sound consumer staple stocks Colgate-Palmolive (CL), Altria Group (MO), and Kroger (KR) for the long haul. Read on.

Many of the recalled products contained a lead concentration more than 200 times greater than the FDA's guidance

With weight loss and diabetes drugs in high demand and short supply, potentially dangerous counterfeits have flooded the market.

Scientists found that contaminated milking equipment can harbor the H5N1 virus for more than an hour, increasing the risk of dairy farmers getting infected.

House Judiciary subcommittee hearing exposes concerns over FDA politicization during pandemic, raising questions about rushed vaccine approvals and adverse...

Federal advisers are making a stronger endorsement for RSV vaccinations for people 75 and older

US health agencies are testing dairy workers and milk products for H5N1 bird flu impact, focusing on virus transmission through raw milk and pasteurization...